567 related articles for article (PubMed ID: 27240600)
1. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
[TBL] [Abstract][Full Text] [Related]
2. Left and right ventricular strain using fast strain-encoded cardiovascular magnetic resonance for the diagnostic classification of patients with chronic non-ischemic heart failure due to dilated, hypertrophic cardiomyopathy or cardiac amyloidosis.
Steen H; Giusca S; Montenbruck M; Patel AR; Pieske B; Florian A; Erley J; Kelle S; Korosoglou G
J Cardiovasc Magn Reson; 2021 Apr; 23(1):45. PubMed ID: 33823860
[TBL] [Abstract][Full Text] [Related]
3. The Most Predictive Red Flags for Suspecting Cardiac Amyloidosis in Patients with Heart Failure with Preserved Ejection Fraction.
Yalvaç HE; Murat S; Ak Sivrikoz İ; Üsküdar Teke H; Çilingir O; Çolak E; Çavuşoğlu Y
Turk Kardiyol Dern Ars; 2024 Jun; 52(4):227-236. PubMed ID: 38829635
[TBL] [Abstract][Full Text] [Related]
4. False Positive in [ 99m Tc]Tc-DPD Scintigraphy for Cardiac Amyloidosis Due to Intravenous Iron Administration.
Rudolphi Solero T; Feriche Aragón M; Amrani Raissouni T; Delgado-García A; Cañada-Rodríguez MJ; Sanz Viedma S
Clin Nucl Med; 2024 Feb; 49(2):e65-e67. PubMed ID: 38048549
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction - implications for clinical trials.
Kanagala P; Cheng ASH; Singh A; McAdam J; Marsh AM; Arnold JR; Squire IB; Ng LL; McCann GP
J Cardiovasc Magn Reson; 2018 Jan; 20(1):4. PubMed ID: 29321034
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy.
Devesa A; Camblor Blasco A; Pello Lázaro AM; Askari E; Lapeña G; Gómez Talavera S; Taibo Urquía M; Rodríguez Olleros C; Tuñón J; Ibáñez B; Aceña Á
ESC Heart Fail; 2021 Aug; 8(4):2856-2865. PubMed ID: 33963812
[TBL] [Abstract][Full Text] [Related]
7. Characteristic cardiac phenotypes are detected by cardiovascular magnetic resonance in patients with different clinical phenotypes and genotypes of mitochondrial myopathy.
Florian A; Ludwig A; Stubbe-Dräger B; Boentert M; Young P; Waltenberger J; Rösch S; Sechtem U; Yilmaz A
J Cardiovasc Magn Reson; 2015 May; 17(1):40. PubMed ID: 26001801
[TBL] [Abstract][Full Text] [Related]
8. Routine 4D Cardiac CT to Identify Concomitant Transthyretin Amyloid Cardiomyopathy in Older Adults with Severe Aortic Stenosis.
Bernhard B; Leib Z; Dobner S; Demirel C; Caobelli F; Rominger A; Schütze J; Grogg H; Alwan L; Spano G; Boscolo Berto M; Lanz J; Pilgrim T; Windecker S; Stortecky S; Gräni C
Radiology; 2023 Dec; 309(3):e230425. PubMed ID: 38085082
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of [
Caobelli F; Gözlügöl N; Bakula A; Rominger A; Schepers R; Stortecky S; Hunziker Munsch L; Dobner S; Gräni C
J Nucl Med; 2024 Jun; 65(6):944-951. PubMed ID: 38724281
[TBL] [Abstract][Full Text] [Related]
10. Regional myocardial microvascular dysfunction in cardiac amyloid light-chain amyloidosis: assessment with 3T cardiovascular magnetic resonance.
Li R; Yang ZG; Wen LY; Liu X; Xu HY; Zhang Q; Guo YK
J Cardiovasc Magn Reson; 2016 Apr; 18():16. PubMed ID: 27048459
[TBL] [Abstract][Full Text] [Related]
11. Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging.
Gotschy A; von Deuster C; van Gorkum RJH; Gastl M; Vintschger E; Schwotzer R; Flammer AJ; Manka R; Stoeck CT; Kozerke S
J Cardiovasc Magn Reson; 2019 Sep; 21(1):56. PubMed ID: 31484544
[TBL] [Abstract][Full Text] [Related]
12. [Cardiac amyloidosis. Invasive and noninvasive diagnosis].
Pinamonti B; Dreas L; Bussani R; Mestroni L; Silvestri F; Tanganelli P; Camerini F
G Ital Cardiol; 1987 Dec; 17(12):1016-30. PubMed ID: 3503797
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.
Mohammed SF; Mirzoyev SA; Edwards WD; Dogan A; Grogan DR; Dunlay SM; Roger VL; Gertz MA; Dispenzieri A; Zeldenrust SR; Redfield MM
JACC Heart Fail; 2014 Apr; 2(2):113-22. PubMed ID: 24720917
[TBL] [Abstract][Full Text] [Related]
14. Serial scanning with
Minutoli F; Di Bella G; Mazzeo A; Laudicella R; Gentile L; Russo M; Vita G; Baldari S
J Nucl Cardiol; 2021 Oct; 28(5):1949-1957. PubMed ID: 31741327
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of heart failure with reduced ejection fraction in patients with transthyretin cardiac amyloidosis.
Asif T; Araujo T; Singh V; Malhotra S
J Nucl Cardiol; 2020 Jun; 27(3):1044-1046. PubMed ID: 32185683
[No Abstract] [Full Text] [Related]
16. Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with heart failure with preserved ejection fraction (HFpEF) in United States.
Lau ATC; DiDomenico RJ; Kim K
Int J Cardiol; 2024 Mar; 398():131598. PubMed ID: 37979789
[TBL] [Abstract][Full Text] [Related]
17. [Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation].
Hongo M; Yamada H; Okubo S; Hirayama J; Fujii T; Kusama S; Ikeda S
J Cardiogr; 1985 Mar; 15(1):163-80. PubMed ID: 2999267
[TBL] [Abstract][Full Text] [Related]
18. Primary amyloid heart disease presenting as hypertrophic obstructive cardiomyopathy.
Weston LT; Raybuck BD; Robinowitz M; Brinker JA; Oetgen WJ
Cathet Cardiovasc Diagn; 1986; 12(3):176-81. PubMed ID: 3015411
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of the PACIFIC-PRESERVED (PhenomApping, ClassIFication and Innovation for Cardiac dysfunction in patients with heart failure and PRESERVED left ventricular ejection fraction) study.
Hulot JS; Janiak P; Boutinaud P; Boutouyrie P; Chézalviel-Guilbert F; Christophe JJ; Cohen A; Damy T; Djadi-Prat J; Firat H; Hervé PY; Isnard R; Jondeau G; Mousseaux E; Pernot M; Prot P; Tyl B; Soulat G; Logeart D;
Arch Cardiovasc Dis; 2024 May; 117(5):332-342. PubMed ID: 38644067
[TBL] [Abstract][Full Text] [Related]
20. Current Status of Radionuclide Imaging of Transthyretin Cardiac Amyloidosis.
Waheed A; Dorbala S
Cardiol Clin; 2023 May; 41(2):217-231. PubMed ID: 37003679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
